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EDITORIAL FOREWORD
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Clinical Interventions in Aging: a forum for practitioners of evidence-
based “anti-aging medicine”
In 1990, data from an article published in the New England Journal of Medicine
suggested that the age-related decline in human growth hormone (hGH) production
contributes, at least in part, to senescence (Rudman et al 1990). Youthful changes in
body composition associated with hGH administration to elderly men gave rise to
the idea that replacement of vital substances such as hormones, cofactors,
neurotransmitters, antioxidants, and other intrinsic factors that decline during aging
might oppose or even reverse senescence. Adoption of this concept by healthcare
providers during the 1990s resulted in the coining of the now popular term, “anti-
aging medicine”. At first, the practice of replacement therapy to maintain health and
vitality during aging seemed reasonable and scientifically valid. However,
overinterpretation and sensational reporting of research data by the media misled
many lay persons into believing that the means to reverse aging had been discovered.
Public enthusiasm for access to the “fountain of youth” presented a great opportunity
for entrepreneurs and charlatans to sell “anti-aging” products without providing
evidence of their safety and efficacy. Eventually, commercial interests that exploited
the public desire for enduring youth had tainted anti-aging medicine and raised
concern among many healthcare professionals that the field was illegitimate.
Commercialism also significantly reduced the availability of private and public
research funds that could have helped expand upon the legitimate, original findings.
This created significant obstacles to generating a database of information on safe,
effective, and practical methods for increasing longevity with good quality of life
during aging. The use of anti-aging products by those concerned with protecting
their professional and ethical reputations became something of a liability (Wick 2002).
Nonetheless, public interest in anti-aging therapies, especially those involving
hormone and other vital substance replacement, continues and in many cases is
growing. As a result, many physicians and healthcare providers have been forced to
treat their patients without the benefit of reliable information that could be provided
by professionally organized educational programs, seminars, and evidence-based,
peer-reviewed reports from their colleagues in research and practice.
A forum has been organized in recognition of the need for a reliable source of
scientifically valid information on interventions in aging. Its purpose is to serve the
needs and interests of medical practitioners whose practices include some aspect of
longevity medicine. The forum includes a new international organization called the
Society for Applied Research in Aging (SARA) and its official, peer-reviewed journal,
Clinical Interventions in Aging (CIA). As a first step, SARA will sponsor, jointly
with the University of South Florida College of Medicine, an organizational and
charter member meeting and symposium in Tampa, FL, USA on October 28–30,
2005. All speakers will be experts in their field and have peer-reviewed publications
demonstrating their competence. Participation is open to all physicians and healthcare
providers, and SARA will take applications for charter membership at the meeting.
The Society will offer a unique opportunity for members to contribute to the
development of longevity medicine while at the same time provide the means to gain
recognition of their skills and elevate their professional status among peers and patients
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alike. Achievement of these goals will be facilitated by
participation in Society activities including the Institutional
Review Board-approved clinical trials of hormone
replacement therapies, protocols, and treatment paradigms
for a variety of clinical situations; e-consult services/chat
rooms for questions and debate of controversial issues; and
training sessions/focus groups for intensive analysis of
specific subjects. University-based, continuing medical
educational credits (CME) will be provided for participation
at many Society functions. As the result of participation,
members will gain basic information on how the use of
exercise, diet, nutrition and natural products, hormone and
antioxidant replacement therapies, chelation and
acupuncture, meditation, and other approaches may help
promote and extend healthy life. They will also come to
understand the risks and benefits of interventions in aging
as well as some of the legal and ethical questions relevant
to the healthcare practitioner. Through such professional
development, the practitioner will more easily discriminate
between legitimate and unfounded claims about healthy
aging and longevity.
Most importantly, members will receive subscriptions
to CIA and will also be provided with instruction and
assistance on gathering outcomes of their work, analyzing
data, and creating publishable articles. Clinical Interventions
in Aging will provide anti-aging practitioners the opportunity
to gather information and communicate new perspectives,
questions, and issues of importance to their peers through
its pages. A major objective of SARA is to collect and report
outcomes from studies of aging and its treatments; therefore,
submissions of manuscripts for publication in CIA will be
solicited as a major part of the Society’s efforts. The journal
is devoted to reporting the outcomes of current research and
therapies that increase our knowledge of how the aging
process can be better managed. Its highly respected editorial
board will ensure publication of only the highest quality,
peer-reviewed reports. In recognition of the value of clinical
data and the relevance of such information to the needs of
longevity medicine practitioners, the journal’s format will
include observations, case reports, new techniques,
subjective conclusions and opinions, letters, and relevant
articles. These submissions will be held to the same high
standards for publication as are basic and clinical research
papers. Accordingly, they should complement practical
information on current treatments as reported by other
practitioners. The journal will also periodically publish an
educational section on current topics in longevity and
integrative medicine for which CME credits as well as those
for related healthcare professionals (CPE) will be offered.
As Founding Editor of Clinical Interventions in Aging,
I am proud to be part of these worthy efforts. I thank Dove
Medical Press for giving me the opportunity to be integral
to the initiatives that will make the practice of longevity
medicine more interactive among its practitioners, and
through their complementary efforts, bring the practice of
“anti-aging medicine” to unprecedented levels of excellence.
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